title: Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans.
abstract: Mice infected intratracheally with Cryptococcus neoformans (Cne) require CD4 and CD8 T cells, IFN-gamma, and M phi production of nitric oxide (NO) for effective resolution of the pulmonary infection. Differences exist among strains of mice in clearing the infection. C.B-17 mice reduced Cne lung burden at a significantly greater rate than C57BL/6 (B6) mice and resistance correlated with greater IFN-gamma production by C.B-17 lung-associated lymph node cells. We examined whether the differences observed in the ability of B6 vs C.B-17 mice to clear Cne was due to 1) numbers of inflammatory cells recruited to the lung, 2) the activation state of the recruited cells as measured by expression of inducible nitric oxide synthase (iNOS), and/or 3) the in vivo production of NO as measured by quantitating urine nitrates. The level of iNOS protein was identical in lungs from both strains of mice during Cne infection as determined by Western blot analysis of whole lung homogenates and immunocytochemistry of isolated lung macrophages. Surprisingly, in vivo studies of iNOS activity indicated that NO production in B6 mice was significantly less than that in C.B-17 mice. While single cell suspensions from lungs of either mouse strain produced identical amounts of NO, NO production by lung explants paralleled in vivo urinary nitrate excretion, suggesting that the maintenance of pulmonary architecture and cell-cell interaction was necessary for suppression of iNOS activity in B6 mice. These data strongly implicate the existence of mechanisms that regulate NO production at the level of enzyme activity during infections and have important implications for analyzing the role of iNOS during an immune response in in vivo models.
authors.affiliation: Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque 87131, USA.
authors.forename: J
authors.initials: J
authors.lastname: Lovchik
authors.forename: M
authors.initials: M
authors.lastname: Lipscomb
authors.forename: C R
authors.initials: CR
authors.lastname: Lyons
mesh_terms: D000818:Animals; D003453:Cryptococcosis / Q000201:enzymology* / Q000276:immunology* / Q000473:pathology; D007113:Immunity, Innate; D008172:Lung Diseases, Fungal / Q000201:enzymology* / Q000276:immunology* / Q000473:pathology; D008262:Macrophage Activation; D051379:Mice; D009566:Nitrates / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D013045:Species Specificity
chemical_list: D009566:Nitrates; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase